drugset / Trial / NCT00518232
A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to investigate the clinical benefit of switching children with ADHD from immediate-release methylphenidate (IR-MPH) to OROS-methylphenidate under the correct dosage conversion scheme.
Timeline
- Start
- 2006-09
- Primary completion
- 2007-06
- Completion
- 2007-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylphenidate | Small molecule | 18 mg | — |
| Subject | Methylphenidate | Small molecule | 36 mg | — |
| Subject | Methylphenidate | Small molecule | 54 mg | — |